Cases & Deals

Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to OxyContin® against Intellipharmaceutics

Clients Purdue Pharma L.P.

Jones Day is representing Purdue Pharma L.P. in a Hatch-Waxman patent infringement action against defendants, relating to the defendants' submission of a Section 505(b)(2) New Drug Application to the FDA seeking approval of an extended-release oxycodone formulation.

Purdue Pharma L.P., et al. v. Intellipharmaceutics International Inc., et al., Nos. 1-17-cv-00392, 1-18-cv-00404 (D. Del.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.